ambroxol presentation

Presentationon

WinkofAmbroxol Hydrocloride BP

Presented byMd. Wahid RezwanExecutive, PMDChemist Laboratories Ltd.Cell: 880001716356956E-mail: rezwanwahid@gmail.com

Executive SummaryExecutive Summary

Brand Name : Winkof

Generic Name : Ambroxol Hydrochloride BP

Therapeutic Class : Mucoactive Agent

Dosage Form : Syrup

Strength : 100ml

Flavor : Banana

Winkof Carton

Winkof Sticker

General Information

Winkof (Ambroxol Hydrochloride) is a Mucoactive

agent used in the treatment of

respiratory diseases associated with

excessive mucus.

Mucus

Mucus is a slippery secretion produced by mucus membranes. It is a normal protective layering around the airway, eye and urinary tract.

Mucus is an adhesive gel produced in the airway by submucosal glands

and goblet cells and

is principally water.

Mucous cells on the stomach lining

PhlegmPhlegm

Phlegm is more related to disease than is mucus. Phlegm is a secretion in the airway during disease and inflammation. Phlegm usually contains mucus with bacteria, dust.

Once phlegm has been expectorated by a cough

it becomes sputum.

CiliaCilia

Cilia are short, hair-like, rhythmically beating

organelles on the surface of certain cells.

It moves or expels fluids, abnormal

phlegm , dust particles and microbes

by their conveyor belt like action.

CiliaCilia

CiliaCilia

CoughCough

A cough is a sudden and often repetitively

occurring reflex which helps to clear the large

breathing passages from secretions, irritants,

foreign particles and microbes.

Classification:1. Non Productive cough ( Dry Cough )

2. Productive cough ( Wet cough )

WinkofAmbroxol Hydrochlorid BP

Drugs of Respiratory SystemDrugs of Respiratory System

Product Information

Winkof is a preparation of Ambroxol Hydrochloride.

It possesses both Expectorant & Mucolytic effects.

It increases bronchial secretion and decreases viscosity to

make coughs more productive.

It dilutes the thick mucus in the respiration track and

facilitates excretion of it.

IndicationsIndications

• Acute I Chronic Bronchitis Gi Kvi‡b m„ó k¦vmZ‡š¿i Cough `~i K‡i|

• Laryngitis, Pharyngitis, Sinusitis BZ¨vw` †iv‡Mi Kvi‡b m„ó Cough, ey‡K e¨v_v I Mjvi e¨v_v `~i K‡i|

• Asthmatic Bronchitis Gi Kvi‡b m„ó njy` ev meyR Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i|

• Bronchiectasis Gi Kvi‡b m„ó `~M©Ühy³ njy` ev meyR Cough `~i K‡i|

• Chronic Pneumonia Gi Kvi‡b m„ó Nb Cough, ey‡K e¨v_v I k¦vmKó `~i K‡i|

Mechanism of ActionMechanism of Action

Winkof

Expectorant Mucolytic

Increases the bronchial secretion

Breakdown of Acid Mucopolysaccharide Fiber

Lubricate the irritated Respiratory Tract

Thinner & Watery mucus

Increased mucus flow by cilia through coughing

DosageDosage

Adult (Above 10years) : 10ml ( 2 Spoonful ) 2-3times

Child :

(5-10 Years) : 5ml (1 Spoonful) 2-3times

(2-5 Years) : 2.5ml (1/2 Spoonful) 2-3times

(1-2 Years) : 1.5ml 2times

(6-12 Months) : 1ml 2times

(0-6 months) : 0.5ml (2 times daily)

Current Market situation :

   Market Size

Cr. TK. Growth % Market Share

  COUGH & COLD PREPARATIONS 115.51 19.56 13.91  EXPECTORANTS 68.78 13.55 59.54     AMBROXOL 33.91 12.93 49.30

Brand Name Company      

AMBROX SQUARE 15.95 12.82 47.04

BOXOL OPSONIN 4.32 63.79 12.77

AMBOLYT INCEPTA 4.23 35.71 12.48

LYTEX IBN SINA 1.62 9.53 4.79

MYROX ACI 1.04 -31.14 3.09

SWOT Analysis

Strengths Weaknesses

1. We have more than 700 Field Force.

2. We’ve Dynamic Leaders like you3. We have 555 Doctors (MBBS&

above)4. We have 593 Doctors (Below

MBBS)

1. Late entry

2. Poor product knowledge

3. No list of Specialized Doctors

4. Lack of monitoring.

Opportunities Threats

1. High growth rate market.

2. Better than Cough Suppressants

3. We’ve got Winter Season

1. Aggressive competitor activity

Qualitative :Qualitative :

Make Winkof as an Established

Brand by creating complete Brand

Awareness.

To hold a Good Position in the

market.

Proper use of Promo Materials.

QuantitativeQuantitative : :

Brand Sales/Month (Unit)Sales/Month (Tentative

Value)

Winkof 30,000 7.5 Lac

Monthly Sales target :

Rx Analysis

Category Number of FF Exp. Rx / Day Est. Rx/ MonthTotal Tentative Value/ Month

A 100 3 7,200

6.72 LacB 150 2 7,200

C 200 1 4,800

Total 450 1.78 19,200

If 30% System loss = 10 Lac

If 100% of Trader’s sales = 13.5 Lac

Target Doctors

• Chest Specialists• Medicine Specialists• Child Specialists• GPs• RMPs/PCs

As well as Chemist Shop

MonitoringMonitoring Activities Activities

Ensure 100% utilization of Logistics and Samples.

Gifts must be distributed through Joint Call (By Leader + Promoter).

Strict monitoring and emphasizing on poor performance Area.

Maintain Daily Communication with Team Leader.

THANKSTHANKS